The Australian Government Rural Industries and Research Development Corporation (RIRDC) has identified Tri-Solfen (the Australian developed wound healing and pain management product for animals) as the number 1 registration priority for the Sheep, Cattle, Pig and Alpaca industries. The priority list was released on the RIRDC website www.rirdc.gov.au/agvet
Tri-Solfen’s wound healing and pain relief technology addresses animal welfare concerns raised by major retailers and consumer groups regarding farming husbandry procedures in livestock, providing improved animal productivity, less pain, and resulting better welfare outcomes.
Tri-Solfen has been proven effective in farm husbandry procedures such as tail docking, castration, dehorning, branding and other accidental wounds, further having the potential to reduce or eliminate the need for the use of antibiotics in the food chain that has traditionally occurred during some of these procedures. Currently Trisolfen is registered for the Australian sheep industry for routine fly strike surgery, treating 3 million merino lambs per annum.
“We are now working with livestock industry groups, the Australian Regulator (APVMA) and industry levy bodies ( MLA and AWI ) to ensure Tri-Solfen is approved for use in other livestock procedures ” states Allan Giffard, Managing Director of Animal Ethics. “ Also, other countries have taken interest in our work, as we recently began work trialling Trisolfen in the EU with Portugal University on dehorning wound and pain management, so these issues are international and growing” says Giffard.
Animal Ethics Pty Ltd was also recently granted patents in the EU, USA, Canada and NZ, paving the way for the wound healing and pain relief technology to be commercialised in these international animal health markets.
For Information regarding Tri-Solfen and the technology please visit www.animalethics.com.au . Media Contact: Allan Giffard ph. +61 (0)419 362 283